Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Pdl Biopharma Inc (PDLI)

2.86 0.1 (3.62%)

05-22 16:00

Open:

2.76

Pre. Close:

2.76

High:

2.88

Low:

2.755

Volume:

1,987,095

Market Cap:

431M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.882 - 2.896

2.896 - 2.909

Low:

2.726 - 2.741

2.741 - 2.756

Close:

2.834 - 2.859

2.859 - 2.882

Technical analysis  (as of: 2018-05-22 4:41:53 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 3.47     One year: 3.69

Support:

Support1: 2.66    Support2: 2.21

Resistance:

Resistance1: 2.97    Resistance2: 3.16

Pivot:

2.88

Moving Averages:

MA(5): 2.76     MA(20): 2.89

MA(100): 2.81     MA(250): 2.83

MACD:

MACD(12,26): -0.04     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 27.33     %D(3): 19.80

RSI:

RSI(14): 48.88

52-Week:

High: 3.55  Low: 2.15  Change(%): 23.3

Average Vol(K):

3-Month: 164190  10-Days 164754

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PDLI has closed above bottom band by 46.3%. Bollinger Bands are 46.1% wider than normal. The large width of the bands suggest high volatility as compared to PDLI's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

2018-05-21T09:00:00-04:00
PDL BioPharma Names Dr. Jill Jene Vice President, Business Development

2018-05-15T07:00:00-04:00
PDL BioPharma to Present at Two Upcoming Investor Conferences

2018-05-11T19:20:51-04:00
PDL BioPharma's (PDLI) CEO John McLaughlin on Q1 2018 Results - Earnings Call Transcript

2018-05-10T09:21:03-04:00
Premarket Losers as of 9:05 am (5/10/2018)

2018-05-09T16:03:00-04:00
PDL BioPharma EPS of $0.01

2018-05-09T16:01:00-04:00
PDL BioPharma Announces First Quarter 2018 Financial Results

2018-05-02T07:00:00-04:00
PDL BioPharma to Announce First Quarter 2018 Financial Results on May 9, 2018

2018-04-24T14:28:02-04:00
By The Numbers: Healthcare Stocks With Big Cash Distributions

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

151.64

Shares Float (M)

144.28

% Held by Insiders

4.80

% Held by Institutions

98.40

Shares Short (K)

17988

Shares Short Prior Month (K)

20360

Stock Financials

EPS

0.650

EPS Est. Current Year

0.610

EPS Est. Next Year

0.410

EPS Est. Next Quarter

0.130

Forward EPS

0.250

Book Value (p.s.)

0.510

PEG Ratio

0.82

Profit Margin

39.46

Operating Margin

10.04

Return on Assets (ttm)

9.0

Return on Equity (ttm)

13.9

Qtrly Rev. Growth

12.9

Gross Profit (p.s.)

1.296

Sales Per Share

EBITDA (p.s.)

1.071

Qtrly Earnings Growth

Operating Cash Flow (M)

40.62

Levered Free Cash Flow (M)

235.79

atoplab.com

Valuation

P/E

4.40

P/E Growth Ratio

0.04

P/BV

5.61

P/S

478700416.00

P/CF

10.68

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2016-06-13

Ex-Dividend Date

2016-06-02

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.